STASSI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 18.969
EU - Europa 9.246
AS - Asia 7.454
SA - Sud America 1.193
Continente sconosciuto - Info sul continente non disponibili 1.091
AF - Africa 213
OC - Oceania 21
Totale 38.187
Nazione #
US - Stati Uniti d'America 18.605
SG - Singapore 2.666
IT - Italia 2.387
RU - Federazione Russa 2.211
CN - Cina 1.800
BR - Brasile 941
FI - Finlandia 855
DE - Germania 818
HK - Hong Kong 796
UA - Ucraina 676
VN - Vietnam 647
GB - Regno Unito 473
PL - Polonia 437
FR - Francia 348
IE - Irlanda 347
JP - Giappone 259
BD - Bangladesh 258
KR - Corea 194
CA - Canada 179
SE - Svezia 178
IN - India 173
NL - Olanda 152
ID - Indonesia 89
TR - Turchia 86
AR - Argentina 77
BE - Belgio 74
MX - Messico 72
MY - Malesia 69
IQ - Iraq 64
CI - Costa d'Avorio 62
RO - Romania 62
AT - Austria 55
EC - Ecuador 41
UZ - Uzbekistan 41
ES - Italia 39
VE - Venezuela 37
IR - Iran 34
SA - Arabia Saudita 34
ZA - Sudafrica 33
CO - Colombia 30
KE - Kenya 29
PK - Pakistan 29
CZ - Repubblica Ceca 26
CL - Cile 24
NP - Nepal 23
TH - Thailandia 22
PH - Filippine 21
CR - Costa Rica 20
GR - Grecia 19
JM - Giamaica 19
PY - Paraguay 19
MA - Marocco 18
AU - Australia 17
DZ - Algeria 17
CH - Svizzera 16
HN - Honduras 16
AE - Emirati Arabi Uniti 15
JO - Giordania 15
KZ - Kazakistan 14
TN - Tunisia 14
BG - Bulgaria 12
EG - Egitto 12
AZ - Azerbaigian 11
KG - Kirghizistan 11
TT - Trinidad e Tobago 11
DO - Repubblica Dominicana 10
ET - Etiopia 10
IL - Israele 10
OM - Oman 9
TW - Taiwan 9
UY - Uruguay 9
BH - Bahrain 8
PE - Perù 8
QA - Qatar 8
RS - Serbia 8
BO - Bolivia 7
EU - Europa 7
LB - Libano 7
PT - Portogallo 7
PA - Panama 6
GT - Guatemala 5
HU - Ungheria 5
KW - Kuwait 5
LT - Lituania 5
NG - Nigeria 5
NI - Nicaragua 5
PR - Porto Rico 5
PS - Palestinian Territory 5
SV - El Salvador 5
AL - Albania 4
AM - Armenia 4
BB - Barbados 4
HR - Croazia 4
LU - Lussemburgo 4
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
A1 - Anonimo 2
Totale 37.058
Città #
Ashburn 2.221
Fairfield 2.131
Singapore 1.844
Chandler 1.150
San Jose 1.111
Woodbridge 1.107
Houston 899
Wilmington 790
Cambridge 788
Seattle 780
Ann Arbor 765
Hong Kong 761
Palermo 651
Moscow 401
Zgierz 383
Jacksonville 370
Dublin 344
Council Bluffs 305
New York 300
Los Angeles 269
Beijing 264
Medford 262
Santa Clara 253
Tokyo 243
Ho Chi Minh City 220
Helsinki 219
The Dalles 219
Boardman 214
Des Moines 214
Frankfurt am Main 201
Dallas 199
Hefei 196
Nanjing 183
Altamura 175
Princeton 173
Lauterbourg 170
Hanoi 164
Lawrence 141
San Diego 138
Buffalo 128
Rome 125
Milan 114
Chicago 113
Dearborn 109
London 100
Tulsa 99
São Paulo 94
Ludwigshafen am Rhein 76
Phoenix 68
Brussels 62
Abidjan 61
Orem 59
Seoul 57
Nuremberg 55
Jakarta 54
Munich 54
Columbus 52
Nanchang 49
Berlin 47
Changsha 47
Amsterdam 46
Toronto 46
Shenyang 44
Seongnam 43
Brooklyn 41
Falls Church 39
Kuala Selangor 39
Tianjin 39
Warsaw 39
Bremen 37
Hebei 37
Izmir 37
Denver 36
Kumar 36
Montreal 36
Rio de Janeiro 36
Stockholm 36
Tashkent 36
Atlanta 35
Da Nang 33
Shanghai 33
Guangzhou 32
Jinan 31
Lappeenranta 31
Paris 31
Chennai 30
Haiphong 30
San Paolo di Civitate 29
Naples 28
Poplar 27
Catania 26
Jiaxing 26
Redwood City 26
Saint Petersburg 26
Venice 25
Baghdad 24
City of London 24
Nairobi 24
Vienna 24
Roden 23
Totale 24.162
Nome #
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis 486
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients 424
High Levels of Exogenous C2-Ceramide Promote Morphological and Biochemical Evidences of Necrotic Features in Thyroid Follicular Cells 399
Cancer stem cell definitions and terminology: the devil is in the details 389
Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling 349
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition 349
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 333
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 316
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 309
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 309
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 308
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage 307
Tumor and its microenvironment: a synergistic interplay. 305
Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown 304
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 304
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 303
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells 294
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 293
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities 287
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. 285
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 280
Colorectal cancer defeating? Challenge accepted! 278
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models 275
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells 272
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 271
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer 269
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 263
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy 259
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. 258
Survivin is regulated by interleukin-4 in colon cancer stem cells 257
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis 253
CANCER STEM CELLS CONTRIBUTE TO THE AGGRESSIVE BEHAVIOUR OF HUMAN EPITHELIAL COLON CANCER. 248
Normal vs cancer thyroid stem cells: the road to transformation 248
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 246
Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism. 246
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 246
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells 244
Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy 244
Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy 243
Immunotherapy targeting colon cancer stem cells 240
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. 240
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes 239
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 237
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 236
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. 236
Colorectal Cancer Stem Cells: From the Crypt to the Clinic 234
Innovative Therapeutic Strategies Targeting Colorectal Cancer Stem Cells 234
Cancer cell targeting by CAR-T cells: A matter of stemness 233
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 232
Meeting the Challenge of Targeting Cancer Stem Cells 231
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 229
C1Q+ TPP1+ macrophages promote colon cancer progression through SETD8-driven p53 methylation 229
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells 229
Isolation and culture of colon cancer stem cells. 229
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment 228
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 227
Differentiation, phenotype, and function of interleukin-17-producing human V{gamma}9V{delta}2 T cells 225
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 225
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging 222
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs 221
Autocrine production of IL-4 confers resistance to chemotherapy and CD-95 induced cell death in cancer cells. 220
Therapeutic implications of Cancer Initiating Cells. 217
Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells 216
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 216
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 215
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. 214
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. 214
A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening 213
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 213
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy 212
Estrogens and stem cells in thyroid cancer 211
ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREAMENT OF CANCER 209
Tumorigenic and metastatic activity of human thyroid cancer stem cells 209
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 209
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 208
γδ T cells as a potential tool in colon cancer immunotherapy 207
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype 206
Colon cancer stem cells: promise of targeted therapy. 204
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme 201
Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 201
IL-4-mediated drug resistance in colon cancer stem cells 200
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 200
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells 200
Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patients 199
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs 198
Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform. 198
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules 197
Cancer-Initiating Cells from Colorectal cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 197
CD133 as a target for colon cancer. 193
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells 191
Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells 190
Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease 188
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing igand–Mediated Destruction. 187
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. 187
Colorectal cancer stem cells and cell death 186
Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids 186
A versatile ultrasound system for in vitro experiments 185
IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. 184
Role of interleukin-4 on colon cancer stem cell survival 183
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 183
Totale 24.456
Categoria #
all - tutte 129.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.476 0 503 100 82 151 97 143 140 301 319 187 453
2022/20233.272 310 584 59 404 343 564 184 225 370 39 129 61
2023/20241.506 88 211 93 91 116 301 161 98 17 48 18 264
2024/20254.035 110 257 196 339 141 140 300 316 283 525 526 902
2025/202614.077 1.071 376 851 1.080 1.295 2.050 1.940 1.308 1.099 1.801 682 524
2026/2027938 679 259 0 0 0 0 0 0 0 0 0 0
Totale 38.187